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1140-165 Long-Term Statin Treatment Protects Against Nitrate-
Induced Oxidative Stress
Anne Otto, David Fontaine, Jeanine Fontaine, Guy Berkenboom, Institute of Pharmacy, 
ULB, Brussels, Belgium, Erasme Hospital, ULB, Brussels, Belgium
Background:Nitrate tolerance is associated with an enhanced superoxide anion produc-
tion and could be attenuated by statins as they interact with the two main (eNOS and
NAD(P)H oxidase) pathways involved in this oxidative stress.
Methods: 3 groups of normocholesterolemic rats were treated; group 1 received rosuvas-
tatin (10 mg/kg/d p.o) for 5 weeks and the last 3 days a cotreatment with the statin plus
nitroglycerin (NTG 50 mg/kg/d, sub-cutaneous injections b.i.d.); group 2 received only
NTG (50 mg/kg/d, b.i.d. for 3 days) and group 3 served as control. Rings of thoracic aor-
tas from these groups were studied in organ baths. Relaxations to NTG (0.1 nM to 0.1
mM) were determined on phenylephrine-preconstricted rings and O2- production
(counts/10s/mg) was assessed by lucigenin chemiluminescence technique.
Results: In group 2 (NTG), the concentration-response curves to NTG were significantly
shifted to the right : the pD2 (-log NTG concentration evoking a half maximal relaxation)
was 6.76+/-0.06 (n=7) vs 7.77+/-0.08 (n=7) in group 3 (not exposed to NTG, P<0.01) ;
O2- production was enhanced (289+/-23 (n=6) vs 183+/-34 (n=5, P<.05)). In contrast, in
group 1, the rightward shift was attenuated (pD2 values was 7.19+/-0.11 (n=8), P<.05 vs
group 2); O2- production was decreased : 208+/-19 (n=6, P<.05 vs group 2). In addition,
before NTG exposure, rosuvastatin treatment decreased p22phox (the essential
NAD(P)H subunit) abundance in aortic wall and NAD(P)H oxidase activity. In contrast,
this treatment did not alter either eNOS abundance or the basal release of endothelium-
derived NO.
Conclusion: Long-term rosuvastatin treatment protects against nitrate tolerance by coun-
teracting NTG-induced increase in O2- production. This protection seems to involve a
direct interaction with the NAD(P)H oxidase pathway rather than an upregulation of the
eNOS pathway.
1140-166 Enhancing Arteriogenesis Increases Atherosclerosis 
and Reducing Atherosclerosis Reduces Arteriogenesis: 
Demonstration of the Concept in Mice
Mary Susan Burnett, Tim Kinnaird, Eugenio Stabile, Cheol Whan Lee, Matie Shou, 
Stephen E. Epstein, MedStar Research Institute, Washington, DC
Background: Inflammatory and immune cells are known to contribute to atherogenesis.
We and others have reported data indicating that such cells also enhance collateral
development. We have used two mouse models with different predispositions to both ath-
erosclerosis and collateral development to gain insight into this “trade-off” phenomenon.
It is our hypothesis that: Shared inflammatory mechanisms contribute to atherogenesis
and to arteriogenesis; stimulating these pathways will activate both processes. Consider-
ation of these findings will be important in developing clinical strategies designed to
enhance collaterals or prevent atherosclerosis in patients.
Methods: Aortic lesion area was assessed in 16 week, chow fed Balb/c and C57BL/6J
ApoE-/- mice (n=20) using Oil Red O staining and computer assisted morphometric anal-
ysis. Total serum cholesterol was quantified. To examine collateral development, at 12
weeks, C57BL/6J and Balb/c animals (n=10) underwent left femoral artery ligation. Flow
recovery was assessed using Laser Doppler Perfusion Imaging over a 4 week period and
expressed as a ratio of ischemic to normal limb flows. 
Results: The C57BL/6J ApoE -/- mice had greater lesion area when compared to Balb/c
ApoE-/- mice, although the Balb/c ApoE-/- mice had higher serum cholesterol levels.
[C57BL/6J ApoE -/- vs. Balb/c ApoE-/-: Lesion area (µm2) ; 22,081 +/-2646 vs. 8062 +/-
1429, p< 0.0001, cholesterol levels (mg/dl); 840+/-49 vs. 960 +/-38, p<0.039]. Blood flow
recovery was significantly better in C57BL/6J compared to Balb/C [0.652 vs 0.306 at day-
7, 0.806 vs 0.519 at day-28, p<0.001 for trend by ANOVA]. 
Conclusions: The C57BL/6J mouse is more susceptible to atherosclerosis than the
Balb/c strain; however, the C57BL/6J strain exhibits a marked improvement in collateral
flow during recovery from femoral artery ligation that is not observed in the Balb/c mouse.
These data support our hypothesis that shared mechanisms contribute to both athero-
sclerosis and arteriogenesis, and set the stage for future studies to examine this “trade-
off” phenomenon in greater detail.
1140-167 Cytomegalovirus Impairs Endothelial Nitric Oxide 
Synthase Pathway: Role of Oxidative Stress and Viral 
Entry
Katsuya Iijima, Satoshi Noda, Karsten Sydow, Edward S. Mocarski, John P. Cooke, 
Stanford University School of Medicine, Palo Alto, CA
Background: Seroepidemiological and histopathological evidence has implicated CMV in
pathogenesis of atherosclerosis. We hypothesized CMV may accelerate atherogenesis
by impairing endothelial nitric oxide synthase (NOS) pathway. An important determinant
of NOS activity is ADMA (asymmetric dimethylarginine), an endogenous inhibitor of
NOS. Methods and Results: To determine whether CMV impairs the NOS pathway by
increasing ADMA accumulation, cultured human microvascular endothelial cells (EC)
were infected with endotheliotrophic human CMV strain, TB40/E, at MOI 1, 3, and 10.
HPLC analysis of the conditioned medium showed a dose-dependent increase in ADMA
accumulation. The increase in ADMA was associated with a decline in intracellular cGMP
(by 43%) indicating inhibition of the NOS pathway. We hypothesized accumulation of
ADMA was due to its impaired degradation by enzyme dimethylarginine dimethylamino-
hydrolase (DDAH). Indeed, the CMV-induced increase in ADMA after 72h infection was
temporally associated with a marked reduction (over 80%) in DDAH activity, which is
impaired by oxidative stress. CMV dose- and time-dependently increased generation of
intracellular O2-derived free radicals using FACS analysis and a fluorescent marker,
DCFDA. Surprisingly, the CMV-induced increase of oxidative stress did not require viral
replication because UV-inactivated virus induced the same response, but did require
binding and entry of viral particles because neutralizing antibody to the virus blocked its
effects to increase ADMA. Tegument proteins carried by CMV are known to modulate
immunological response in infected cells, and could be responsible for the observed
effects. One of these proteins, phosphoprotein 65, was detected within EC by immunoflu-
orescent staining even after exposure to UV inactivated virus. Conclusion: CMV infection
impairs the NOS pathway by inducing an oxidative impairment of DDAH which leads to
accumulation of the NOS inhibitor ADMA. This effect of CMV on EC does not require viral
gene replication, but does require viral binding and entry, suggesting release of one or
more viral tegument proteins after viral entry may be responsible for derangement of the
NOS pathway.
1140-168 In Vivo Caspase-Inhibition Prevents Plaque Progression 
by Reducing Apoptosis and Tissue-Factor Expression 
in a Mouse Model of Chronic Atherosclerosis
Randolph Hutter, Carolina Valdiviezo, Gurusher Panjrath, Bernhard Sauter, Francine 
Carrick, Valentin Fuster, Juan Jose Badimon, Mount Sinai School of Medicine, New York, 
NY
Background: Lipid lowering therapy has been shown to reduce thrombogenicity of ath-
erosclerotic plaques. Inflammatory cells undergoing apoptosis when exposed to ox-LDL
in lipid-rich plaque can contribute to plaque thrombogenicity via synthesis of tissue-factor
(TF). Therefore, increased intimal apoptosis and tissue-factor expression could be a key
factor for accelerating plaque progression. To test this hypothesis we evaluated the effect
of caspase-inhibition (CI) in a mouse model of atherosclerosis in vivo.
Methods: Apo-E -/- mice (n=13) were fed a Western Diet for 7 months. Three animals
were sacrificed at 7 month and served as baseline control (BL). The remaining animals
were randomized into treatment (TR) (n=5) and control group (CT) (n=5) receiving either
3 weeks of continuous CI (daily i.p. injection of 30 mcg/kg of Q-VD-OPH general
caspase-inhibitor in 50 mcl DMSO) (n=5) or DMSO treatment alone (n=5) (data as
mean±SEM). Plasma cholesterol levels were similar in all groups with 780±58mg/dl for
the BSL group, and 958±64mg/dl and 854±56mg/dl for the TR and CT group. Atheroscle-
rosis was assessed by (immuno)histo-morphometric analysis of the aortic root and by
Sudan IV stainings of whole-mounted abdominal aorta.
Results: CI significantly reduced plaque size compared to controls (0.59±0.05 vs.
0.88±0.04, P<.01). Lipid deposition (Sudan IV) of abdominal aorta was also significantly
reduced by CI compared to CT and BSL. Expression of both aCS-3 and TF in intimal
cells was significantly reduced by CI compared to CT and BSL (aCS3: 9%±2 vs. 30%±3,
P<.01; 9%±2 vs. 23%±3, P<.01; TF: 15%±2 vs. 41%±3, P<.01, 15%±2 vs. 43%±5,
P<.01) and correlated positively with plaque size (P<.05). Double-labeling demonstrated
co-localization of TF and aCS-3.
Conclusion: CI inhibited plaque progression and reversed the increased intimal expres-
sion of both apoptosis and TF despite persistently elevated blood lipid levels. These find-
ings point to intimal apoptosis and associated tissue-factor expression as a possible final
common pathway involved in plaque progression. Therefore, CI could be a powerful tool
to protect intimal cells from diverse pro-apoptotic stimuli leading to a better treatment of
atherosclerosis.
1140-169 Heavy Coronary Plaque Calcification Is Associated With 
Only Minor Degrees of Plaque Macrophage and 
Neovessel Density Than Plaques With Less 
Calcification: Solving the Calcium Paradox?
Silvio Litovsky, Deborah Vela, Allen Burke, Mohammad Madjid, Morteza Naghavi, Saeed 
Payvar, Renu Virmani, Ward Casscells, Texas Heart Institute, Houston, TX, Armed 
Forces Institute of Pathology, Washington, DC
Background. Carotid symptomatic plaques are usually severely calcified. There is
greater variability in that respect with the coronary arteries especially in cases of thin cap
fibroatheromas leading to cap ruptures, where severe calcification may occur but is not
the norm. In the present work we compared plaques with heavy calcification with plaques
with less calcification with regards to macrophage infiltration and neovascularization. 
Methods. Coronary artery section from ten patients with plaque ruptures and of ten
patients with fibrocalcific plaques were obtained from the Armed Forces Institute of
Pathology files. Plaques were routinely decalcified prior to processing. We performed
immunohistochemistry for detection of neovascularization with the endothelial cell mark-
ers factor VIII and for macrophages with the Kp-1 marker. Morphometric computerized
analysis was performed with Olympus MicroSuite software
Results. When the calcification was mild, not reaching the superficial third of the plaque,
it coexisted with a lipid necrotic core and was accompanied by a significant macrophage
infiltration in the plaque and neovascularization (the latter more prominent in the underly-
ing media and adventitia). Areas of heavy calcification (even in the same cross-section)
were associated with loss of lipid core, decrease to almost absence of macrophages and
neovessels density.
Conclusion. The study suggests a plausible explanation for the apparent paradox of cal-
cium being a marker of plaque vulnerability and at the same time providing protection to
the plaque. Mild/moderate calcification is associated with known markers of vulnerable
